In a minority (estimated at 10-20%) of patients with TBMN and heterozygous mutation of COL4A3, 4 or 5 there is progressive renal dysfunction with end stage renal disease (ESRD) in later life, usually after the fifth decade [2]. This evidence concerns the gene COL4A3 and stage 5 chronic kidney disease.